MedTrace Logo

Evaluation of Probiotics on Symptoms of Upper Respiratory Tract Infections

NCT00599430 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 326

Last updated 2008-01-23

No results posted yet for this study

Summary

The aim of the present prospective study is to investigate whether the consumption of certain probiotic strains over a six-month winter/spring season would be able to affect the incidence and duration of upper respiratory tract infections, in otherwise healthy children as well as determining whether a combination of two strains would perform differently from a single strain version.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

Placebo

Inert excipient

DIETARY_SUPPLEMENT

Lactobacillus acidophilus NCFM

1e10 CFU/day

DIETARY_SUPPLEMENT

Combination of Lactobacillus acidophilus and Bifidobacterium lactis

1x10e10 CFU/day

Sponsors & Collaborators

  • Danisco

    lead INDUSTRY

Principal Investigators

  • Charlie Zhang · Sprim Advanced Life Sciences

  • Cheryl Riefer · Sprim Advanced Life Sciences

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
5 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-11-30
Primary Completion
2006-05-31
Completion
2006-05-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00599430 on ClinicalTrials.gov